{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T04:33:12Z","timestamp":1775017992164,"version":"3.50.1"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T00:00:00Z","timestamp":1689206400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,3,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Coronavirus disease 2019 (COVID-19) has potential risks for both clinically worsening pulmonary hypertension (PH) and increasing mortality. However, the data regarding the protective role of vaccination in this population are still lacking. This study aimed to assess the safety of approved vaccination for patients with PH.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>In this national prospective cohort study, patients diagnosed with PH (World Health Organization [WHO] groups 1 and 4) were enrolled from October 2021 to April 2022. The primary outcome was the composite of PH-related major adverse events. We used an inverse probability weighting (IPW) approach to control for possible confounding factors in the baseline characteristics of patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>In total, 706 patients with PH participated in this study (mean age, 40.3 years; mean duration after diagnosis of PH, 8.2 years). All patients received standardized treatment for PH in accordance with guidelines for the diagnosis and treatment of PH in China. Among them, 278 patients did not receive vaccination, whereas 428 patients completed the vaccination series. None of the participants were infected with COVID-19 during our study period. Overall, 398 patients received inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine, whereas 30 received recombinant protein subunit vaccine. After adjusting for baseline covariates using the IPW approach, the odds of any adverse events due to PH in the vaccinated group did not statistically significantly increase (27\/428 [6.3%] <jats:italic toggle=\"yes\">vs.<\/jats:italic> 24\/278 [8.6%], odds ratio = 0.72, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.302). Approximately half of the vaccinated patients reported at least one post-vaccination side effects, most of which were mild, including pain at the injection site (159\/428, 37.1%), fever (11\/428, 2.6%), and fatigue (26\/428, 6.1%).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>COVID-19 vaccination did not significantly augment the PH-related major adverse events for patients with WHO groups 1 and 4 PH, although there were some tolerable side effects. A large-scale randomized controlled trial is warranted to confirm this finding. The final approval of the COVID-19 vaccination for patients with PH as a public health strategy is promising.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cm9.0000000000002767","type":"journal-article","created":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T11:00:08Z","timestamp":1689246008000},"page":"669-675","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Vaccination against coronavirus disease 2019 in patients with pulmonary hypertension: A national prospective cohort study"],"prefix":"10.1097","volume":"137","author":[{"given":"Xiaohan","family":"Wu","sequence":"first","affiliation":[{"name":"Department of Cardiology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingyi","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jieling","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Cardiology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianqian","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Echocardiography, National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Circulation, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai 200433, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongjian","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Cui","sequence":"additional","affiliation":[{"name":"Department of Cardiology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anyi","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cenjin","family":"Wen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luhong","family":"Qiu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinjian","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiqi","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xijie","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunyan","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Cardiology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duolao","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhicheng","family":"Jing","sequence":"additional","affiliation":[{"name":"Department of Cardiology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2023,7,13]]},"reference":[{"key":"R2-20250602","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41577-020-00480-0","article-title":"Viral targets for vaccines against COVID-19","volume":"21","author":"Dai","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"R3-20250602","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/s41577-021-00592-1","article-title":"Progress of the COVID-19 vaccine effort: Viruses, vaccines and variants versus efficacy, effectiveness and escape","volume":"21","author":"Tregoning","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"R5-20250602","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.jacc.2021.02.017","article-title":"ACC health policy statement on cardiovascular disease considerations for COVID-19 vaccine prioritization","volume":"77","author":"Driggin","year":"2021","journal-title":"J Am Coll Cardiol."},{"key":"R6-20250602","first-page":"933","article-title":"Chinese guidelines for the diagnosis and treatment of pulmonary hypertension 2018 (in Chinese)","volume":"46","year":"2018","journal-title":"Chin J Cardiol"},{"key":"R7-20250602","doi-asserted-by":"crossref","first-page":"1700745","DOI":"10.1183\/13993003.00745-2017","article-title":"Pulmonary vascular endothelium: The orchestra conductor in respiratory diseases: Highlights from basic research to therapy","volume":"51","author":"Huertas","year":"2018","journal-title":"Eur Respir J"},{"key":"R8-20250602","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1378\/chest.06-2913","article-title":"Registry and survival study in Chinese patients with idiopathic and familial pulmonary arterial hypertension","volume":"132","author":"Jing","year":"2007","journal-title":"Chest"},{"key":"R9-20250602","doi-asserted-by":"crossref","first-page":"1801913","DOI":"10.1183\/13993003.01913-2018","article-title":"Haemodynamic definitions and updated clinical classification of pulmonary hypertension","volume":"53","author":"Simonneau","year":"2019","journal-title":"Eur Respir J"},{"key":"R10-20250602","first-page":"1927","article-title":"Incidence and risk factors of chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism","volume":"7","author":"Yang","year":"2015","journal-title":"J Thorac Dis"},{"key":"R11-20250602","doi-asserted-by":"crossref","first-page":"00520","DOI":"10.1183\/23120541.00520-2020","article-title":"COVID-19 in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: A reference centre survey","volume":"6","author":"Belge","year":"2020","journal-title":"ERJ Open Res"},{"key":"R12-20250602","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1513\/AnnalsATS.202005-521OC","article-title":"A survey-based estimate of COVID-19 incidence and outcomes among patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension and impact on the process of care","volume":"17","author":"Lee","year":"2020","journal-title":"Ann Am Thorac Soc"},{"key":"R13-20250602","doi-asserted-by":"crossref","first-page":"e056345","DOI":"10.1136\/bmjopen-2021-056345","article-title":"Vaccination coverage among COVID-19 prevention and control management teams at primary healthcare facilities in China and their attitudes towards COVID-19 vaccine: A cross-sectional online survey","volume":"12","author":"Yan","year":"2022","journal-title":"BMJ Open"},{"key":"R14-20250602","doi-asserted-by":"crossref","first-page":"2045894020920153","DOI":"10.1177\/2045894020920153","article-title":"Care of patients with pulmonary arterial hypertension during the coronavirus (COVID-19) pandemic","volume":"10","author":"Ryan","year":"2020","journal-title":"Pulm Circ"},{"key":"R15-20250602","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1055\/a-1661-0240","article-title":"Pulmonary hypertension and COVID-19","volume":"42","author":"Castiglione","year":"2022","journal-title":"Hamostaseologie"},{"key":"R16-20250602","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.hfc.2022.07.003","article-title":"Management of COVID-19 in patients with pulmonary arterial hypertension","volume":"19","author":"Farmakis","year":"2023","journal-title":"Heart Fail Clin"},{"key":"R17-20250602","doi-asserted-by":"crossref","first-page":"573","DOI":"10.7326\/0003-4819-147-8-200710160-00010","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies","volume":"147","author":"von Elm","year":"2007","journal-title":"Ann Intern Med"},{"key":"R18-20250602","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1080\/01621459.1994.10476818","article-title":"Estimation of regression coefficients when some regressors are not always observed","volume":"89","author":"Robins","year":"1994","journal-title":"J Am Stat Assoc"},{"key":"R20-20250602","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0140-6736(21)01429-X","article-title":"Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): Interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey","volume":"398","author":"Tanriover","year":"2021","journal-title":"Lancet"},{"key":"R21-20250602","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ijid.2021.11.009","article-title":"Real-world effectiveness of COVID-19 vaccines: A literature review and meta-analysis","volume":"114","author":"Zheng","year":"2022","journal-title":"Int J Infect Dis"},{"key":"R22-20250602","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1056\/NEJMoa2202261","article-title":"Efficacy and safety of the RBD-dimer-based COVID-19 vaccine ZF2001 in adults","volume":"386","author":"Dai","year":"2022","journal-title":"N Engl J Med"},{"key":"R23-20250602","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.3390\/vaccines9121395","article-title":"COVID-19 vaccination in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Safety profile and reasons for opting against vaccination","volume":"9","author":"Wieteska-Mi\u0142ek","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"R24-20250602","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s11883-021-00973-w","article-title":"Moving the needle on atherosclerotic cardiovascular disease and heart failure with influenza vaccination","volume":"23","author":"Behrouzi","year":"2021","journal-title":"Curr Atheroscler Rep"},{"key":"R25-20250602","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1111\/bjhp.12468","article-title":"Towards intervention development to increase the uptake of COVID-19 vaccination among those at high risk: Outlining evidence-based and theoretically informed future intervention content","volume":"25","author":"Williams","year":"2020","journal-title":"Br J Health Psychol"},{"key":"R26-20250602","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3390\/vaccines9030292","article-title":"COVID-19 vaccination willingness among Chinese adults under the free vaccination policy","volume":"9","author":"Liu","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"R27-20250602","doi-asserted-by":"crossref","first-page":"111205","DOI":"10.1016\/j.jtbi.2022.111205","article-title":"The effectiveness of various control strategies: An insight from a comparison modelling study","volume":"549","author":"Zhou","year":"2022","journal-title":"J Theor Biol"},{"key":"R28-20250602","doi-asserted-by":"crossref","first-page":"8767","DOI":"10.3390\/ijerph19148767","article-title":"The advantages of the zero-COVID-19 strategy","volume":"19","author":"Su","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"R29-20250602","doi-asserted-by":"crossref","first-page":"951941","DOI":"10.3389\/fpubh.2022.951941","article-title":"Analysis of China's fight against COVID-19 from the perspective of policy tools-policy capacity","volume":"10","author":"Zhu","year":"2022","journal-title":"Front Public Health"},{"key":"R30-20250602","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/d41586-022-04235-w","article-title":"Can China avoid a wave of deaths if it lifts strict zero COVID policy?","volume":"612","author":"Mallapaty","year":"2022","journal-title":"Nature"},{"key":"R31-20250602","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0140-6736(22)00094-0","article-title":"Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): A phase 4, non-inferiority, single blind, randomised study","volume":"399","author":"Costa Clemens","year":"2022","journal-title":"Lancet"},{"key":"R32-20250602","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S1473-3099(21)00127-4","article-title":"Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: Two randomised, double-blind, placebo-controlled, phase 1 and 2 trials","volume":"21","author":"Yang","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"R33-20250602","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1186\/s13063-020-04775-4","article-title":"Double-blind, randomized, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of treating healthcare professionals with the adsorbed COVID-19 (inactivated) vaccine manufactured by Sinovac\u2013PROFISCOV: A structured summary of a study protocol for a randomised controlled trial","volume":"21","author":"Palacios","year":"2020","journal-title":"Trials"},{"key":"R34-20250602","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1186\/s12879-015-1154-y","article-title":"Frequency and impact of confounding by indication and healthy vaccinee bias in observational studies assessing influenza vaccine effectiveness: A systematic review","volume":"15","author":"Remschmidt","year":"2015","journal-title":"BMC Infect Dis"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000002767","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T19:04:52Z","timestamp":1748891092000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000002767"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,13]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/cm9.0000000000002767","relation":{},"ISSN":["0366-6999","2542-5641"],"issn-type":[{"value":"0366-6999","type":"print"},{"value":"2542-5641","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,13]]},"assertion":[{"value":"2023-04-17","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}}]}}